A Phase 1 Dose Escalation and Expanded Cohort Study of P-MUC1C-ALLO1 in Adult Subjects With Advanced or Metastatic Solid Tumors

Disease Name: 
Solid Tumors
Study Status: 
Date: 
April 25, 2023